130 related articles for article (PubMed ID: 24950002)
1. A novel ApoA-I truncation (ApoA-IMytilene) associated with decreased ApoA-I production.
Anthanont P; Polisecki E; Asztalos BF; Diffenderfer MR; Barrett PH; Millar JS; Billheimer J; Cuchel M; Rader DJ; Schaefer EJ
Atherosclerosis; 2014 Aug; 235(2):470-6. PubMed ID: 24950002
[TBL] [Abstract][Full Text] [Related]
2. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.
Rached F; Santos RD; Camont L; Miname MH; Lhomme M; Dauteuille C; Lecocq S; Serrano CV; Chapman MJ; Kontush A
J Lipid Res; 2014 Dec; 55(12):2509-20. PubMed ID: 25341944
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
[TBL] [Abstract][Full Text] [Related]
4. Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).
Wada M; Iso T; Asztalos BF; Takama N; Nakajima T; Seta Y; Kaneko K; Taniguchi Y; Kobayashi H; Nakajima K; Schaefer EJ; Kurabayashi M
Atherosclerosis; 2009 Nov; 207(1):157-61. PubMed ID: 19473658
[TBL] [Abstract][Full Text] [Related]
5. A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.
Han H; Sasaki J; Matsunaga A; Hakamata H; Huang W; Ageta M; Taguchi T; Koga T; Kugi M; Horiuchi S; Arakawa K
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1447-55. PubMed ID: 10364075
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
7. A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians.
Dastani Z; Dangoisse C; Boucher B; Desbiens K; Krimbou L; Dufour R; Hegele RA; Pajukanta P; Engert JC; Genest J; Marcil M
Atherosclerosis; 2006 Mar; 185(1):127-36. PubMed ID: 16023124
[TBL] [Abstract][Full Text] [Related]
8. Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux.
Anthanont P; Asztalos BF; Polisecki E; Zachariah B; Schaefer EJ
J Clin Lipidol; 2015; 9(3):390-5. PubMed ID: 26073399
[TBL] [Abstract][Full Text] [Related]
9. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
10. Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
Hancock-Cerutti W; Millar JS; Valentini S; Liu J; Billheimer JT; Rader DJ; Cuchel M
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833954
[TBL] [Abstract][Full Text] [Related]
11. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency.
Santos RD; Schaefer EJ; Asztalos BF; Polisecki E; Wang J; Hegele RA; Martinez LR; Miname MH; Rochitte CE; Da Luz PL; Maranhão RC
J Lipid Res; 2008 Feb; 49(2):349-57. PubMed ID: 17991756
[TBL] [Abstract][Full Text] [Related]
12. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.
Brousseau ME; Eberhart GP; Dupuis J; Asztalos BF; Goldkamp AL; Schaefer EJ; Freeman MW
J Lipid Res; 2000 Jul; 41(7):1125-35. PubMed ID: 10884295
[TBL] [Abstract][Full Text] [Related]
13. Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease.
Schaefer JR; Schweer H; Ikewaki K; Stracke H; Seyberth HJ; Kaffarnik H; Maisch B; Steinmetz A
Atherosclerosis; 1999 May; 144(1):177-84. PubMed ID: 10381291
[TBL] [Abstract][Full Text] [Related]
14. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease.
Miller M; Aiello D; Pritchard H; Friel G; Zeller K
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1242-7. PubMed ID: 9714130
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.
Millar JS; Duffy D; Gadi R; Bloedon LT; Dunbar RL; Wolfe ML; Movva R; Shah A; Fuki IV; McCoy M; Harris CJ; Wang MD; Howey DC; Rader DJ
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):140-6. PubMed ID: 18988892
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.
Ng DS; Leiter LA; Vezina C; Connelly PW; Hegele RA
J Clin Invest; 1994 Jan; 93(1):223-9. PubMed ID: 8282791
[TBL] [Abstract][Full Text] [Related]
18. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease.
Asztalos BF; Brousseau ME; McNamara JR; Horvath KV; Roheim PS; Schaefer EJ
Atherosclerosis; 2001 May; 156(1):217-25. PubMed ID: 11369017
[TBL] [Abstract][Full Text] [Related]
19. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
[TBL] [Abstract][Full Text] [Related]
20. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I.
Emmerich J; Vergès B; Tauveron I; Rader D; Santamarina-Fojo S; Shaefer J; Ayrault-Jarrier M; Thiéblot P; Brewer HB
Arterioscler Thromb; 1993 Sep; 13(9):1299-306. PubMed ID: 8364014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
